Superficial Vein Thrombosis

Also known as: Thrombosis venous superficial / Superficial thrombosis of veins / Superficial vein thrombosis (disorder) / Superficial venous thrombosis (& [leg]) or superficial thrombophlebitis / Superficial phlebothrombosis

Drug	Drug Name	Drug Description
DB01109	Heparin	An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation.

Drug	Drug Name	Target	Type
DB01109	Heparin	Antithrombin-III	target
DB01109	Heparin	Coagulation factor X	target
DB01109	Heparin	P-selectin	target
DB01109	Heparin	Heparanase	enzyme
DB01109	Heparin	Fibroblast growth factor receptor 4	target
DB01109	Heparin	Fibroblast growth factor 4	target
DB01109	Heparin	Fibroblast growth factor 19	target
DB01109	Heparin	Fibroblast growth factor receptor 1	target
DB01109	Heparin	Fibroblast growth factor 1	target
DB01109	Heparin	Fibroblast growth factor receptor 2	target
DB01109	Heparin	Fibroblast growth factor 2	target
DB01109	Heparin	Platelet factor 4	target
DB01109	Heparin	Hepatocyte growth factor	target

Drug	Drug Name	Phase	Status	Count
DB00569	Fondaparinux	3	Completed	1
DB11728	Fondaparinux	3	Completed	1
DB06228	Rivaroxaban	3	Completed	1
DB00569	Fondaparinux	4	Completed	1